Systems and methods for automated and interactive analysis of bone scan images for detection of metastases
Inventors
Sjöstrand, Karl Vilhelm • Richter, Jens Filip Andreas • Edenbrandt, Lars
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
Presented herein are systems and methods that provide for improved computer aided display and analysis of nuclear medicine images. In particular, in certain embodiments, the systems and methods described herein provide improvements to several image processing steps used for automated analysis of bone scan images for assessing cancer status of a patient. For example, improved approaches for image segmentation, hotspot detection, automated classification of hotspots as representing metastases, and computation of risk indices such as bone scan index (BSI) values are provided.
Core Innovation
The invention provides a processor-based method for lesion marking and quantitative analysis of nuclear medicine images of a human subject. The method accesses a bone scan image set obtained following administration of an agent to the human subject and automatically segments each image to identify skeletal regions of interest corresponding to anatomical regions of a skeleton, including a femur region and a humerus region, thereby generating an annotated set of images for downstream hotspot processing.
The method automatically detects an initial set of one or more hotspots, where each hotspot corresponds to an area of elevated intensity in the annotated set of images. Hotspot detection uses intensities of pixels in the annotated set of images and one or more region-dependent threshold values, including values associated with the femur region and/or the humerus region that provide enhanced hotspot detection sensitivity to compensate for reduced uptake of the agent therein, including a first reduced intensity threshold value for the femur/humerus that is lower than a second threshold value for one or more other skeletal regions of interest.
For each hotspot in the initial set, the method extracts a set of hotspot features and calculates a metastasis likelihood value corresponding to a likelihood of the hotspot representing a metastasis based on the hotspot features. The method then causes rendering of a graphical representation of at least a portion of the initial set of hotspots for display within a graphical user interface (GUI). The invention is also embodied as a system and a computer aided image analysis device that implement the same lesion marking and quantitative analysis workflow.
Claims Coverage
The independent claims cover a processor-implemented method and corresponding system/device for lesion marking and quantitative analysis, with three core inventive feature areas: skeletal region segmentation including femur/humerus, region-dependent hotspot detection using a reduced threshold for femur/humerus, and metastasis likelihood calculation with GUI rendering. Additional claim coverage adds an intended-use label for the computer aided device.
Lesion marking and quantitative analysis of nuclear medicine bone scan image sets
A processor-based method that accesses a bone scan image set for the human subject obtained following administration of an agent, and performs lesion marking and quantitative analysis on the nuclear medicine images.
Automatically segment skeletal regions of interest including femur and humerus
Automatically segment each image in the bone scan image set to identify one or more skeletal regions of interest corresponding to particular anatomical regions, wherein the skeletal regions of interest comprise at least one of a femur region corresponding to a portion of a femur and a humerus region corresponding to a portion of a humerus.
Region-dependent hotspot detection with reduced femur/humerus intensity threshold
Automatically detect an initial set of one or more hotspots corresponding to areas of elevated intensity using intensities of pixels and one or more region-dependent threshold values, including one or more values associated with the femur region and/or the humerus region that provide enhanced hotspot detection sensitivity to compensate for reduced uptake of the agent, where a first reduced intensity threshold value associated with the femur region and/or the humerus region is lower than a second threshold value associated with one or more other skeletal regions of interest.
Hotspot features and per-hotspot metastasis likelihood calculation
For each hotspot in the initial set, extract a set of hotspot features and calculate a metastasis likelihood value corresponding to a likelihood of the hotspot representing a metastasis based on the set of hotspot features.
Graphical rendering of hotspots within a GUI
Cause rendering of a graphical representation of at least a portion of the initial set of hotspots for display within a graphical user interface (GUI).
Computer aided image analysis device with label specifying trained user context
A computer aided image analysis device comprising the system for lesion marking and quantitative analysis and a label specifying that the device is intended to be used by trained healthcare professionals and/or researchers.
Collectively, the independent claims cover automatic segmentation of skeletal regions of interest including femur and/or humerus, automatic detection of hotspots using region-dependent pixel-intensity thresholds with a reduced threshold for femur/humerus, extraction of hotspot features, calculation of a metastasis likelihood value per hotspot, and GUI rendering of hotspot representations, with additional scope requiring a label specifying intended use by trained healthcare professionals and/or researchers for the computer aided device.
Stated Advantages
Increases detection sensitivity in the femur region and/or the humerus region by using a first reduced intensity threshold value lower than a second threshold value associated with other skeletal regions.
Documented Applications
Lesion marking and quantitative analysis of nuclear medicine bone scan images of a human subject after administration of an agent, including rendering hotspots and calculating metastasis likelihood values.
Evaluation and/or detection of metastatic cancer.
Evaluation and/or detection of prostate cancer.
Interested in licensing this patent?